PMC:7317273 / 21116-21329 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T141","span":{"begin":159,"end":163},"obj":"Body_part"}],"attributes":[{"id":"A141","pred":"fma_id","subj":"T141","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T46","span":{"begin":159,"end":163},"obj":"Body_part"}],"attributes":[{"id":"A46","pred":"uberon_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T107","span":{"begin":18,"end":36},"obj":"Disease"}],"attributes":[{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0002771"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T246","span":{"begin":44,"end":46},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T247","span":{"begin":159,"end":163},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T248","span":{"begin":159,"end":163},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T84","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"T85","span":{"begin":99,"end":109},"obj":"Chemical"}],"attributes":[{"id":"A84","pred":"chebi_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/CHEBI_22907"},{"id":"A85","pred":"chebi_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/CHEBI_45863"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"LitCovid-PubTator","denotations":[{"id":"327","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"328","span":{"begin":99,"end":109},"obj":"Chemical"},{"id":"336","span":{"begin":18,"end":36},"obj":"Disease"},{"id":"337","span":{"begin":159,"end":173},"obj":"Disease"}],"attributes":[{"id":"A327","pred":"tao:has_database_id","subj":"327","obj":"MESH:D001761"},{"id":"A328","pred":"tao:has_database_id","subj":"328","obj":"MESH:D017239"},{"id":"A336","pred":"tao:has_database_id","subj":"336","obj":"MESH:D011658"},{"id":"A337","pred":"tao:has_database_id","subj":"337","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"LitCovid-sentences","denotations":[{"id":"T327","span":{"begin":49,"end":179},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T26","span":{"begin":18,"end":36},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0002206"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"2_test","denotations":[{"id":"32592163-25986930-140679197","span":{"begin":44,"end":46},"obj":"25986930"},{"id":"32592163-28153512-140679198","span":{"begin":175,"end":177},"obj":"28153512"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T361","span":{"begin":0,"end":9},"obj":"CHEBI:22907;CHEBI:22907"},{"id":"T362","span":{"begin":18,"end":27},"obj":"UBERON:0002048"},{"id":"T363","span":{"begin":68,"end":90},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T364","span":{"begin":99,"end":109},"obj":"CHEBI:45863;CHEBI:45863"},{"id":"T365","span":{"begin":119,"end":123},"obj":"DG_47"},{"id":"T366","span":{"begin":159,"end":163},"obj":"UBERON:0002048"}],"text":"bleomycin-induced pulmonary fibrosis model [36]. Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. Therefore, in line with above fin"}